Cargando…
Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor
Autores principales: | Chen, Xiangyu, Li, Ren, Pan, Zhiwei, Qian, Chunfang, Yang, Yang, You, Renrong, Zhao, Jing, Liu, Pinghuang, Gao, Leiqiong, Li, Zhirong, Huang, Qizhao, Xu, Lifan, Tang, Jianfang, Tian, Qin, Yao, Wei, Hu, Li, Yan, Xiaofeng, Zhou, Xinyuan, Wu, Yuzhang, Deng, Kai, Zhang, Zheng, Qian, Zhaohui, Chen, Yaokai, Ye, Lilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167496/ https://www.ncbi.nlm.nih.gov/pubmed/32313207 http://dx.doi.org/10.1038/s41423-020-0426-7 |
Ejemplares similares
-
The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity
por: Gao, Leiqiong, et al.
Publicado: (2021) -
Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody
por: Yue, Shuai, et al.
Publicado: (2021) -
Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19
por: Chen, Xiangyu, et al.
Publicado: (2020) -
Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Small-Scale Clinical Trial
por: Lin, Yao, et al.
Publicado: (2022) -
PD-1/PD-L1 blockade restores tumor-induced COVID-19 vaccine bluntness
por: Chen, Xiangyu, et al.
Publicado: (2023)